Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Science. 2013 Nov 29;342(6162):1090-4. doi: 10.1126/science.1243876.
Hepatitis C virus (HCV), a Hepacivirus, is a major cause of viral hepatitis, liver cirrhosis, and hepatocellular carcinoma. HCV envelope glycoproteins E1 and E2 mediate fusion and entry into host cells and are the primary targets of the humoral immune response. The crystal structure of the E2 core bound to broadly neutralizing antibody AR3C at 2.65 angstroms reveals a compact architecture composed of a central immunoglobulin-fold β sandwich flanked by two additional protein layers. The CD81 receptor binding site was identified by electron microscopy and site-directed mutagenesis and overlaps with the AR3C epitope. The x-ray and electron microscopy E2 structures differ markedly from predictions of an extended, three-domain, class II fusion protein fold and therefore provide valuable information for HCV drug and vaccine design.
丙型肝炎病毒(HCV),一种嗜肝病毒,是病毒性肝炎、肝硬化和肝细胞癌的主要病因。HCV 包膜糖蛋白 E1 和 E2 介导融合和进入宿主细胞,是体液免疫反应的主要靶点。以 2.65 埃分辨率解析的与广泛中和抗体 AR3C 结合的 E2 核心晶体结构揭示了一个由中央免疫球蛋白折叠β三明治组成的紧凑结构,两侧是另外两个蛋白层。通过电子显微镜和定点突变鉴定了 CD81 受体结合位点,该位点与 AR3C 表位重叠。X 射线和电子显微镜 E2 结构与延伸的三结构域 II 类融合蛋白折叠的预测明显不同,因此为 HCV 药物和疫苗设计提供了有价值的信息。